Literature DB >> 25533588

The use of low-level electromagnetic fields to suppress atrial fibrillation.

Lilei Yu1, John W Dyer2, Benjamin J Scherlag2, Stavros Stavrakis2, Yong Sha2, Xia Sheng2, Paul Garabelli2, Jerry Jacobson3, Sunny S Po4.   

Abstract

BACKGROUND: Extremely low-level electromagnetic fields have been proposed to cause significant changes in neural networks.
OBJECTIVE: We sought to investigate whether low-level electromagnetic fields can suppress atrial fibrillation (AF).
METHODS: In 17 pentobarbital anesthetized dogs, bilateral thoracotomies allowed the placement of multielectrode catheters in both atria and at all pulmonary veins. AF was induced by rapid atrial pacing (RAP) or programmed atrial extrastimulation. At baseline and end of each hour of RAP, during sinus rhythm, atrial programmed stimulation gave both the effective refractory period (ERP) and the width of the window of vulnerability. The latter was a measure of AF inducibility. Microelectrodes inserted into the anterior right ganglionated plexi recorded neural firing. Helmholtz coils were powered by a function generator inducing an electromagnetic field (EMF; 0.034 μG, 0.952 Hz). The study sample was divided into 2 groups: group 1 (n = 7)-application of EMF to both cervical vagal trunks; group 2 (n = 10)-application of EMF across the chest so that the heart was located in the center of the coil.
RESULTS: In group 1, EMF induced a progressive increase in AF threshold at all pulmonary vein and atrial sites (all P < .05). In group 2, the atrial ERP progressively shortened and ERP dispersion and window of vulnerability progressively increased (P < .05 compared to baseline values) during 3 hours of RAP and then returned to baseline values during 3 hours of combined application of RAP and EMF (P < .05 compared to the end of the third hour of RAP). The frequency and amplitude of the neural activity recorded from the anterior right ganglionated plexi were markedly suppressed by EMF in both groups.
CONCLUSION: Pulsed EMF applied to the vagal trunks or noninvasively across the chest can significantly reverse AF inducibility.
Copyright © 2015 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Autonomic nervous system; Electromagnetic field

Mesh:

Year:  2014        PMID: 25533588     DOI: 10.1016/j.hrthm.2014.12.022

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  6 in total

Review 1.  New approaches for treating atrial fibrillation: Focus on autonomic modulation.

Authors:  Daniel Sohinki; Stavros Stavrakis
Journal:  Trends Cardiovasc Med       Date:  2019-10-31       Impact factor: 6.677

2.  Case Series of Transcutaneous Magnetic Stimulation for Ventricular Tachycardia Storm.

Authors:  Timothy M Markman; Roy H Hamilton; Francis E Marchlinski; Saman Nazarian
Journal:  JAMA       Date:  2020-06-02       Impact factor: 56.272

3.  Noninvasive low-frequency electromagnetic stimulation of the left stellate ganglion reduces myocardial infarction-induced ventricular arrhythmia.

Authors:  Songyun Wang; Xiaoya Zhou; Bing Huang; Zhuo Wang; Liping Zhou; Menglong Wang; Lilei Yu; Hong Jiang
Journal:  Sci Rep       Date:  2016-07-29       Impact factor: 4.379

4.  Non-invasive Autonomic Neuromodulation Is Opening New Landscapes for Cardiovascular Diseases.

Authors:  Mingxian Chen; Songyun Wang; Xuping Li; Lilei Yu; Hui Yang; Qiming Liu; Jianjun Tang; Shenghua Zhou
Journal:  Front Physiol       Date:  2020-12-15       Impact factor: 4.566

Review 5.  Autonomic modulation of ventricular electrical activity: recent developments and clinical implications.

Authors:  Valerie Y H van Weperen; Marc A Vos; Olujimi A Ajijola
Journal:  Clin Auton Res       Date:  2021-09-30       Impact factor: 4.435

6.  Impact of low-level electromagnetic fields on the inducibility of atrial fibrillation in the electrophysiology laboratory.

Authors:  Daniel Sohinki; Joshua Thomas; Benjamin Scherlag; Stavros Stavrakis; Ali Yousif; Sunny Po; Tarun Dasari
Journal:  Heart Rhythm O2       Date:  2021-04-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.